November 2011 - IOZK

Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo

2011-11-30/in Acute Leukemia, International Publications, Newcastle Disease Virus /von 2011-11-30 / Leuk. Res. 2012 May;36(5):634-45

The roles of tumor-derived exosomes in cancer pathogenesis

2011-11-30/in Exosome, International Publications /von 2011-11-30 / Clin. Dev. Immunol. 2011;2011:842849

Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer

2011-11-26/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-11-26 / Vaccine 2012 Jun;30(29):4394-7

Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells

2011-11-23/in Dendritic Cells, Glioblastoma, International Publications /von 2011-11-23 / Int. J. Oncol. 2012 Mar;40(3):764-72

Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity

2011-11-16/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-11-16 / Int. J. Oncol. 2012 Mar;40(3):840-50

Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria

2011-11-16/in Chronic Leukemia, Dendritic Cells, International Publications /von 2011-11-16 / Cancer Immunol. Immunother. 2012 Jun;61(6):865-79

Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo

2011-11-15/in International Publications, Newcastle Disease Virus, NSCLC /von 2011-11-15 / Cancer Lett. 2012 Apr;317(1):56-64

Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial

2011-11-07/in Dendritic Cells, Glioblastoma, International Publications /von 2011-11-07 / World Neurosurg 2012 May-Jun;77(5-6):736-44

Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients

2011-11-02/in Dendritic Cells, International Publications /von 2011-11-02 / J. Immunol. 2011 Dec;187(11):6130-42

Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma

2011-11-01/in Colorectal Cancer, Dendritic Cells, International Publications /von 2011-11-01 / Anticancer Res. 2011 Nov;31(11):3995-4005